Viewing Study NCT01095302


Ignite Creation Date: 2025-12-25 @ 3:56 AM
Ignite Modification Date: 2025-12-26 @ 2:47 AM
Study NCT ID: NCT01095302
Status: COMPLETED
Last Update Posted: 2013-10-16
First Post: 2010-03-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel and Cisplatin in Patients With Solid Tumors
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module